{"id":"https://openalex.org/W2625718262","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.104","title":"PD-L1 expression, Cancer Genome Atlas (TCGA) subtype, and mutational load as independent predictors of response to atezolizumab (atezo) in metastatic urothelial carcinoma (mUC; IMvigor210).","display_name":"PD-L1 expression, Cancer Genome Atlas (TCGA) subtype, and mutational load as independent predictors of response to atezolizumab (atezo) in metastatic urothelial carcinoma (mUC; IMvigor210).","alternate_titles":[],"publication_year":2016,"publication_date":"2016-05-20","ids":{"openalex":"https://openalex.org/W2625718262","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.104","mag":"2625718262"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2016.34.15_suppl.104","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.104","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.104","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2625718262"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050435057","display_name":"Jonathan E. Rosenberg","orcid":"https://orcid.org/0000-0003-2637-4249","observed_orcids":["https://orcid.org/0000-0003-2637-4249"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan E. Rosenberg","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050042851","display_name":"Daniel Peter Petrylak","orcid":"https://orcid.org/0000-0001-6165-5797","observed_orcids":["https://orcid.org/0000-0001-6165-5797"]},"institutions":[{"id":"https://openalex.org/I32971472","display_name":"Yale University","ror":"https://ror.org/03v76x132","country_code":"US","type":"education","lineage":["https://openalex.org/I32971472"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel Peter Petrylak","raw_affiliation_strings":["Yale University, New Haven, CT;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yale University, New Haven, CT;","institution_ids":["https://openalex.org/I32971472"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104031744","display_name":"Michiel Simon Van Der Heijden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Michiel Simon Van Der Heijden","raw_affiliation_strings":["Netherlands Cancer Institute, Amsterdam, Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Cancer Institute, Amsterdam, Netherlands;","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083331837","display_name":"Andrea Necchi","orcid":"https://orcid.org/0000-0002-3007-2756","observed_orcids":["https://orcid.org/0000-0002-3007-2756"]},"institutions":[{"id":"https://openalex.org/I4210156707","display_name":"Fondazione IRCCS Istituto Nazionale dei Tumori","ror":"https://ror.org/05dwj7825","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210156707"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Andrea Necchi","raw_affiliation_strings":["Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy;","institution_ids":["https://openalex.org/I4210156707"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018398274","display_name":"Peter H. O\u2019Donnell","orcid":"https://orcid.org/0000-0003-2650-0049","observed_orcids":["https://orcid.org/0000-0003-2650-0049"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]},{"id":"https://openalex.org/I4390039251","display_name":"University of Chicago Medicine Comprehensive Cancer Center","ror":"https://ror.org/042wftp98","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865","https://openalex.org/I4390039251"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Peter H. O'Donnell","raw_affiliation_strings":["University of Chicago Comprehensive Cancer Center, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Comprehensive Cancer Center, Chicago, IL;","institution_ids":["https://openalex.org/I40347166","https://openalex.org/I4390039251"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027991868","display_name":"Yohann Loriot","orcid":"https://orcid.org/0000-0002-8338-1739","observed_orcids":["https://orcid.org/0000-0002-8338-1739"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Yohann Loriot","raw_affiliation_strings":["Department of Cancer Medicine, Institut Gustave Roussy, Paris-Sud University, Villejuif, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Medicine, Institut Gustave Roussy, Paris-Sud University, Villejuif, France;","institution_ids":["https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003688542","display_name":"Margitta M. Retz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802619606","display_name":"TUM Klinikum","ror":"https://ror.org/04jc43x05","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2802619606","https://openalex.org/I62916508"]},{"id":"https://openalex.org/I62916508","display_name":"Technical University of Munich","ror":"https://ror.org/02kkvpp62","country_code":"DE","type":"education","lineage":["https://openalex.org/I62916508"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Margitta Retz","raw_affiliation_strings":["Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany;","institution_ids":["https://openalex.org/I2802619606","https://openalex.org/I62916508"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044557306","display_name":"Jos\u00e9 Luis Perez\u2010Gracia","orcid":"https://orcid.org/0000-0003-4941-9075","observed_orcids":["https://orcid.org/0000-0003-4941-9075"]},"institutions":[{"id":"https://openalex.org/I4210135003","display_name":"Clinica Universidad de Navarra","ror":"https://ror.org/03phm3r45","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210135003"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Jose Luis Perez-Gracia","raw_affiliation_strings":["Clinica Universidad de Navarra, Pamplona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinica Universidad de Navarra, Pamplona, Spain;","institution_ids":["https://openalex.org/I4210135003"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074756323","display_name":"Joaquim Bellmunt B","orcid":"https://orcid.org/0000-0003-2328-3421","observed_orcids":["https://orcid.org/0000-0003-2328-3421","https://orcid.org/0000-0001-7569-7074"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joaquim Bellmunt","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026717218","display_name":"Petros D. Grivas","orcid":"https://orcid.org/0000-0003-3965-3394","observed_orcids":["https://orcid.org/0000-0003-3965-3394"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Petros Grivas","raw_affiliation_strings":["Cleveland Clinic Taussig Cancer Institute, Cleveland, OH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Taussig Cancer Institute, Cleveland, OH;","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034715033","display_name":"Richard Wayne Joseph","orcid":"https://orcid.org/0000-0001-6102-4661","observed_orcids":["https://orcid.org/0000-0001-6102-4661"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Wayne Joseph","raw_affiliation_strings":["Mayo Clinic, Jacksonville, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Jacksonville, FL;","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073970384","display_name":"Lawrence H. Fong","orcid":"https://orcid.org/0000-0002-6428-428X","observed_orcids":["https://orcid.org/0000-0002-6428-428X"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Fong","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081609371","display_name":"Edward Ernest Kadel","orcid":"https://orcid.org/0000-0003-3030-6628","observed_orcids":["https://orcid.org/0000-0003-3030-6628"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward E. Kadel","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015836366","display_name":"Zachary S. Boyd","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary Boyd","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003498756","display_name":"Dorothee Nickles","orcid":"https://orcid.org/0009-0002-5295-1062","observed_orcids":["https://orcid.org/0009-0002-5295-1062"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dorothee Nickles","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071731260","display_name":"Garrett Michael Frampton","orcid":"https://orcid.org/0000-0002-2361-2750","observed_orcids":["https://orcid.org/0000-0002-2361-2750"]},"institutions":[{"id":"https://openalex.org/I4392738181","display_name":"Foundation Medicine (United States)","ror":"https://ror.org/02ackr434","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4392738181"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Garrett Michael Frampton","raw_affiliation_strings":["Foundation Medicine, Inc., Cambridge, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Foundation Medicine, Inc., Cambridge, MA;","institution_ids":["https://openalex.org/I4392738181"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009855982","display_name":"Richard Bourgon","orcid":"https://orcid.org/0000-0002-5890-4374","observed_orcids":["https://orcid.org/0000-0002-5890-4374"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard Bourgon","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110860414","display_name":"Priti S. Hegde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priti S. Hegde","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011890417","display_name":"Sanjeev Mariathasan","orcid":"https://orcid.org/0000-0001-5034-773X","observed_orcids":["https://orcid.org/0000-0001-5034-773X"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sanjeev Mariathasan","raw_affiliation_strings":["Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5089861374","display_name":"Thomas B. Powles","orcid":"https://orcid.org/0000-0001-7760-4724","observed_orcids":["https://orcid.org/0000-0001-7760-4724"]},"institutions":[{"id":"https://openalex.org/I169248724","display_name":"Royal Free London NHS Foundation Trust","ror":"https://ror.org/04rtdp853","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I169248724"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Thomas Powles","raw_affiliation_strings":["Barts Cancer Institute, Barts Health, and The Royal Free London NHS Foundation Trust, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barts Cancer Institute, Barts Health, and The Royal Free London NHS Foundation Trust, London, United Kingdom;","institution_ids":["https://openalex.org/I169248724","https://openalex.org/I225661044","https://openalex.org/I4405264518"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":19,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":45,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"34","issue":"15_suppl","first_page":"104","last_page":"104"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9564999938011169,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.04149999842047691,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-urothelial-carcinoma","display_name":"metastatic urothelial carcinoma","score":0.9269999861717224},{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.9710000157356262},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.859000027179718},{"id":"https://openalex.org/keywords/tcga-molecular-subtypes","display_name":"TCGA molecular subtypes","score":0.8009999990463257},{"id":"https://openalex.org/keywords/mutational-load","display_name":"mutational load","score":0.8379999995231628},{"id":"https://openalex.org/keywords/effector-cd8-t-cells","display_name":"CD8+ effector T cells","score":0.7350000143051147},{"id":"https://openalex.org/keywords/cxcl9","display_name":"CXCL9","score":0.968999981880188},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.41100001335144043},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8560000061988831},{"id":"https://openalex.org/keywords/imvigor210","display_name":"IMvigor210","score":0.7239999771118164},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.7677143812179565},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7488709688186646},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5002939701080322},{"id":"https://openalex.org/C2778024521","wikidata":"https://www.wikidata.org/wiki/Q55639806","display_name":"Basal (medicine)","level":3,"score":0.46667730808258057},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.45550182461738586},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44343942403793335},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4433605670928955},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44284874200820923},{"id":"https://openalex.org/C2779118045","wikidata":"https://www.wikidata.org/wiki/Q21114021","display_name":"TIGIT","level":4,"score":0.4180909991264343},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.41097697615623474},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4016389846801758},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.3215686082839966},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.29034459590911865},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2016.34.15_suppl.104","doi":"https://doi.org/10.1200/jco.2016.34.15_suppl.104","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2016.34.15_suppl.104","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3006754259","https://openalex.org/W3031433077","https://openalex.org/W2790303407","https://openalex.org/W2886190874","https://openalex.org/W2346719381","https://openalex.org/W2619463261","https://openalex.org/W4393088049","https://openalex.org/W2896714897","https://openalex.org/W3084258788","https://openalex.org/W3007706442"],"abstract_inverted_index":{"104":[0],"Background:":[1],"Biomarkers":[2],"of":[3,6,35,40,144,277,316],"clinical":[4],"benefit":[5],"immunotherapies,":[7],"such":[8],"as":[9,71,95],"non-synonymous":[10],"mutations,":[11],"mutational":[12,246,295],"load,":[13],"PD-L1":[14,56,116,170,188,281],"IHC":[15,64],"and":[16,37,67,149,163,204,218,221,260,268,294,319],"immune":[17,36,118,317],"signatures,":[18],"have":[19],"not":[20,206,222],"been":[21],"systematically":[22],"evaluated":[23],"in":[24,58,175,214,223,228,236,251,306],"mUC":[25,51,307],"patients":[26],"(pts)":[27],"treated":[28,309],"with":[29,69,124,141,208,262,287,310],"anti\u2013PD-L1":[30],"agents.":[31],"Methods:":[32],"Exploratory":[33],"analyses":[34],"genetic":[38],"predictors":[39],"response":[41,70,136,288],"to":[42,111,137,192,289],"atezo":[43,138,311],"were":[44,93,99,156,275],"performed":[45],"on":[46,283],"archival":[47],"tumor":[48,59,186],"specimens":[49],"from":[50],"pts":[52,308],"(NCT02108652":[53],"cohort":[54],"2).":[55],"expression":[57,79,130,143,211,282],"samples":[60,155,181],"was":[61,80,122,139,173,189,212,233,248,285],"assessed":[62],"by":[63,73,82,101,303],"(SP142":[65],"assay)":[66],"associated":[68,123,140,286],"determined":[72],"RECIST":[74],"v1.1":[75],"(central":[76],"review).":[77],"Gene":[78],"quantified":[81],"RNA-seq":[83],"(Illumina":[84],"TruSeq":[85],"RNA":[86],"Access;":[87],"n":[88,108],"=":[89,109,147,152,161,166,242,266,271],"195);":[90],"molecular":[91],"subtypes":[92],"assigned":[94],"per":[96],"TCGA.":[97],"Mutations":[98],"detected":[100],"genomic":[102],"profiling":[103],"(FoundationOne":[104],"315-cancer":[105],"gene":[106,129],"panel;":[107],"150)":[110],"estimate":[112],"overall":[113],"load.":[114],"Results:":[115],"tumor-infiltrating":[117],"cell":[119,187],"(IC)":[120],"status":[121],"CD8+":[125],"T":[126],"effector":[127],"(Teff)":[128],"levels":[131],"(P":[132,146,151,182,241,265,270],"<":[133,183,202,258],"0.0001).":[134],"Notably,":[135],"high":[142],"CXCL9":[145],"0.0057)":[148],"CXCL10":[150],"0.0079).":[153],"Evaluable":[154],"classified":[157],"into":[158],"luminal":[159,179,215,224,237],"(n":[160,165],"73)":[162],"basal":[164,176,194,197,219],"122)":[167],"TCGA":[168,278,292],"subtypes.":[169],"IC":[171,284],"prevalence":[172],"enriched":[174],"(60%)":[177],"vs":[178,198,254],"(23%)":[180],"0.0001);":[184],"elevated":[185,213],"mostly":[190],"restricted":[191],"the":[193,314],"subtype":[195,293],"(39%":[196],"4%":[199],"luminal,":[200],"P":[201,257],"0.0001)":[203,259],"did":[205],"correlate":[207],"ORR.":[209],"Teff":[210],"cluster":[216],"II":[217,238],"III/IV":[220],"I.":[225],"Responses":[226],"occurred":[227],"all":[229],"subtypes,":[230],"but":[231],"ORR":[232],"significantly":[234,249],"higher":[235],"samples:":[239],"34%":[240],"0.0017).":[243],"While":[244],"median":[245],"load":[247,296],"increased":[250],"responders":[252],"(12.4/Mb)":[253],"non-responders":[255],"(6.4/Mb;":[256],"correlated":[261],"both":[263],"PFS":[264],"0.003)":[267],"OS":[269],"0.014),":[272],"these":[273,304],"associations":[274],"independent":[276],"subtype.":[279],"Conclusions:":[280],"atezo.":[290],"Intrinsic":[291],"each":[297],"added":[298],"predictive":[299],"value.":[300],"Simultaneous":[301],"classification":[302],"characteristics":[305],"further":[312],"defines":[313],"drivers":[315],"responsiveness":[318],"may":[320],"suggest":[321],"potential":[322],"combination":[323],"strategies.":[324],"Clinical":[325],"trial":[326],"information:":[327],"NCT02108652.":[328]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2625718262","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":14},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":8}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2017-06-23T00:00:00"}
